- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02647138
The Effect of White Noise In High Noise Environment
Study Overview
Detailed Description
Insomnia patients will be recruited based on their perception of high noise in their apartment. The investigators will screen patients during the first meeting using The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0). At baseline, an Insomnia Severity Index will be administered.
The study will consist of a one week baseline period in which noise levels will be monitored using spectral analysis and decibel levels and sleep duration will be recorded using a subjective sleep log and wrist actigraphy for objective measurement. At the end of the first week an Insomnia Severity Index will be administered.
During the second week, a treatment period with a white noise machine using a fixed decibel level will be installed in the bedrooms of the subjects. The room noise will continue to be monitored via spectral analysis as well as decibel levels while the patients are wearing actigraphs and keeping a sleep log. At the end of the second week an Insomnia Severity Index will be administered.
During the third week, the white noise machine will be removed and the rooms will still be monitored for sound via spectral analysis and decibel levels and the subject will wear an actigraph and keep a sleep log. At the end of the third week an Insomnia Severity Index will be administered.
The investigators will use Analysis of Covariance (ANCOVA) with baseline vs. white noise to analyze differences. The investigators will use an Acute Noise Index, in which noise spikes of 2 standard deviations from the mean of the entire nights decibel levels count as a noise event.
Noise levels in subjects bedroom will be collected throughout the study along with subjects sleep activity using an actigraph and sleep log.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Weill Cornell Medical College Center for Sleep
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria for each participant are as follows: Must be between 18 and 100 years old
- No significant psychiatric conditions based on the The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0)
- Not currently using narcotics, psychotropic or hypnotic medications and willing to refrain from using these medications during the course of the study
- Limits caffeine consumption to less than or equal to 2 coffee servings, or equivalent per day before 12 noon
- Limits alcohol intake to 7-drinks per week and less than or equal to 1 drinks on any one night
- Must adjust alcohol consumption to 7-drinks per week and less than or equal to 1 drink on any one night for at least two weeks before study begins, and must not consume alcohol later than 8pm
- Naps less than or equal to 1-hour per week according to subjective report
- For at least 3 times a week a minimum of 30 minute sleep latency or 30 minutes of total nighttime awakening due to subjective elevated noise.
Exclusion Criteria:
- Exclusion criteria for each participant are as follows: Younger than 18 years old or older than 100 years old
- Significant psychiatric conditions based on the The Mini International Neuropsychiatric Interview 6.0 (MINI 6.0)
- Currently using narcotics, psychotropic or hypnotic medications and not willing to refrain from using these medications during the course of the study
- Does not limit caffeine consumption to less than or equal to 2 coffee servings, or equivalent per day
- Does not limit alcohol intake to 7-drinks per week and less than or equal to 1 drinks on any one night , consumes alcohol later than 8pm
- Naps more than 1-hour per week according to subjective report
- Not at least 3 times a week at least 30 minute sleep latency or not 30 minutes of total nighttime awakening due to subjective elevated noise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: White Noise
Subject will have white noise machine placed in room.
|
exposure to white noise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Latency data using the actigraph
Time Frame: Three weeks
|
Subjects will have three weeks of sleep latency data using the actigraph and this data will be analyzed and presented.
|
Three weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Latency data using sleep diaries
Time Frame: Three Weeks
|
Subjects will have three weeks of sleep latency data using sleep diaries and this data will be analyzed and presented.
|
Three Weeks
|
|
Insomnia Severity Index
Time Frame: Three Weeks
|
Subjects will complete an Insomnia Severity Index at the end of each of the three weeks of the study.
|
Three Weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1502015935
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
Clinical Trials on white noise
-
IRCCS San Raffaele RomaCompletedSpecific Learning Disability | Specific Learning Disorder | ADHD - Attention Deficit Disorder With HyperactivityItaly
-
Tokat Gaziosmanpasa UniversityAnkara Bilkent City Hospital, University of Health SciencesCompleted
-
Celal Bayar UniversityNot yet recruitingNewborn | Breastfeeding | Music | MotherTurkey
-
Scripps HealthRecruitingSleep | Sleep Fragmentation | White Noise | Sleep DurationUnited States
-
Çankırı Karatekin UniversityCompleted
-
Dokuz Eylul UniversityCompletedPain, Acute | NewbornTurkey
-
Agri Ibrahim Cecen UniversityCompletedElective Cesarean Section | Non Stress Test (NST)Turkey (Türkiye)
-
Sanko UniversityCompleted
-
Ataturk UniversityCompleted
-
Chang Gung Memorial HospitalKaohsiung Medical UniversityCompleted